Papers: 25 Feb 2013 - 4 Mar 2013
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
TNF-alpha promotes cerebral pericyte remodeling in vitro, via a switch from alpha1 to alpha2 integrins.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
Effect of 10-day forced treadmill training on neurotrophic factors in experimental autoimmune encephalomyelitis.
Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Ciliary Neurotrophic Factor Role in Myelin Oligodendrocyte Glycoprotein Expression in Cuprizone-Induced Multiple Sclerosis Mice.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome.
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.